These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 24386457)

  • 21. Early-stage epigenetic modification during somatic cell reprogramming by Parp1 and Tet2.
    Doege CA; Inoue K; Yamashita T; Rhee DB; Travis S; Fujita R; Guarnieri P; Bhagat G; Vanti WB; Shih A; Levine RL; Nik S; Chen EI; Abeliovich A
    Nature; 2012 Aug; 488(7413):652-5. PubMed ID: 22902501
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Residual expression of reprogramming factors affects the transcriptional program and epigenetic signatures of induced pluripotent stem cells.
    Sommer CA; Christodoulou C; Gianotti-Sommer A; Shen SS; Sailaja BS; Hezroni H; Spira A; Meshorer E; Kotton DN; Mostoslavsky G
    PLoS One; 2012; 7(12):e51711. PubMed ID: 23272148
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reprogramming of mouse fibroblasts into induced pluripotent stem cells with Nanog.
    Moon JH; Yun W; Kim J; Hyeon S; Kang PJ; Park G; Kim A; Oh S; Whang KY; Kim DW; Yoon BS; You S
    Biochem Biophys Res Commun; 2013 Feb; 431(3):444-9. PubMed ID: 23333380
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Effects of
    Liu H; Liu Z; Gao M; Hu X; Sun R; Shen X; Liu F; Shen J; Shan Z; Lei L
    Cell Reprogram; 2020 Apr; 22(2):90-98. PubMed ID: 32150692
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhanced OCT4 transcriptional activity substitutes for exogenous SOX2 in cellular reprogramming.
    Marthaler AG; Adachi K; Tiemann U; Wu G; Sabour D; Velychko S; Kleiter I; Schöler HR; Tapia N
    Sci Rep; 2016 Jan; 6():19415. PubMed ID: 26762895
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epigenetic memory in induced pluripotent stem cells.
    Kim K; Doi A; Wen B; Ng K; Zhao R; Cahan P; Kim J; Aryee MJ; Ji H; Ehrlich LI; Yabuuchi A; Takeuchi A; Cunniff KC; Hongguang H; McKinney-Freeman S; Naveiras O; Yoon TJ; Irizarry RA; Jung N; Seita J; Hanna J; Murakami P; Jaenisch R; Weissleder R; Orkin SH; Weissman IL; Feinberg AP; Daley GQ
    Nature; 2010 Sep; 467(7313):285-90. PubMed ID: 20644535
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Divergent reprogramming routes lead to alternative stem-cell states.
    Tonge PD; Corso AJ; Monetti C; Hussein SM; Puri MC; Michael IP; Li M; Lee DS; Mar JC; Cloonan N; Wood DL; Gauthier ME; Korn O; Clancy JL; Preiss T; Grimmond SM; Shin JY; Seo JS; Wells CA; Rogers IM; Nagy A
    Nature; 2014 Dec; 516(7530):192-7. PubMed ID: 25503232
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epigenetic Aberrations Are Not Specific to Transcription Factor-Mediated Reprogramming.
    Tiemann U; Wu G; Marthaler AG; Schöler HR; Tapia N
    Stem Cell Reports; 2016 Jan; 6(1):35-43. PubMed ID: 26711876
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intermediate Standstill Clones Trapped in the Reprogramming of Human Fibroblasts to Induced Pluripotent Stem Cells.
    Zhang L; Wang Y; Zhang Y; Wang L; Huang H
    Cell Reprogram; 2020 Apr; 22(2):99-105. PubMed ID: 32182120
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transcriptional and epigenetic mechanisms of cellular reprogramming to induced pluripotency.
    van den Hurk M; Kenis G; Bardy C; van den Hove DL; Gage FH; Steinbusch HW; Rutten BP
    Epigenomics; 2016 Aug; 8(8):1131-49. PubMed ID: 27419933
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Signalling Through Retinoic Acid Receptors is Required for Reprogramming of Both Mouse Embryonic Fibroblast Cells and Epiblast Stem Cells to Induced Pluripotent Stem Cells.
    Yang J; Wang W; Ooi J; Campos LS; Lu L; Liu P
    Stem Cells; 2015 May; 33(5):1390-404. PubMed ID: 25546009
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reprogramming of mouse somatic cells into pluripotent stem-like cells using a combination of small molecules.
    Kang PJ; Moon JH; Yoon BS; Hyeon S; Jun EK; Park G; Yun W; Park J; Park M; Kim A; Whang KY; Koh GY; Oh S; You S
    Biomaterials; 2014 Aug; 35(26):7336-45. PubMed ID: 24881998
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sirt6 regulates efficiency of mouse somatic reprogramming and maintenance of pluripotency.
    Xu P; Wang TT; Liu XZ; Wang NY; Sun LH; Zhang ZQ; Chen HZ; Lv X; Huang Y; Liu DP
    Stem Cell Res Ther; 2019 Jan; 10(1):9. PubMed ID: 30630525
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epithelial cell adhesion molecule (EpCAM) complex proteins promote transcription factor-mediated pluripotency reprogramming.
    Huang HP; Chen PH; Yu CY; Chuang CY; Stone L; Hsiao WC; Li CL; Tsai SC; Chen KY; Chen HF; Ho HN; Kuo HC
    J Biol Chem; 2011 Sep; 286(38):33520-32. PubMed ID: 21799003
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Generation of neural progenitor cells from porcine-induced pluripotent stem cells.
    Machado LS; Pieri NCG; Botigelli RC; de Castro RVG; de Souza AF; Bridi A; Lima MA; Fantinato Neto P; Pessôa LVF; Martins SMMK; De Andrade AFC; Freude KK; Bressan FF
    J Tissue Eng Regen Med; 2020 Dec; 14(12):1880-1891. PubMed ID: 33049106
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Generation of iPSCs from mouse fibroblasts with a single gene, Oct4, and small molecules.
    Li Y; Zhang Q; Yin X; Yang W; Du Y; Hou P; Ge J; Liu C; Zhang W; Zhang X; Wu Y; Li H; Liu K; Wu C; Song Z; Zhao Y; Shi Y; Deng H
    Cell Res; 2011 Jan; 21(1):196-204. PubMed ID: 20956998
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Continuous passages accelerate the reprogramming of mouse induced pluripotent stem cells.
    Shan ZY; Wu YS; Li X; Shen XH; Wang ZD; Liu ZH; Shen JL; Lei L
    Cell Reprogram; 2014 Feb; 16(1):77-83. PubMed ID: 24387163
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The levels of reprogramming factors influence the induction and maintenance of pluripotency: the case of CD1 mouse strain cells.
    Covarrubias L; Martínez-Sarmiento JÁ; Valencia C; Nagy A; Hernández-García D
    Int J Dev Biol; 2021; 65(4-5-6):365-376. PubMed ID: 32930373
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Contribution of hepatic lineage stage-specific donor memory to the differential potential of induced mouse pluripotent stem cells.
    Lee SB; Seo D; Choi D; Park KY; Holczbauer A; Marquardt JU; Conner EA; Factor VM; Thorgeirsson SS
    Stem Cells; 2012 May; 30(5):997-1007. PubMed ID: 22378611
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Understanding the roadmaps to induced pluripotency.
    Liu K; Song Y; Yu H; Zhao T
    Cell Death Dis; 2014 May; 5(5):e1232. PubMed ID: 24832604
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.